These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7744825)

  • 21. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase.
    Camps M; Nichols A; Gillieron C; Antonsson B; Muda M; Chabert C; Boschert U; Arkinstall S
    Science; 1998 May; 280(5367):1262-5. PubMed ID: 9596579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SH2 domain-containing tyrosine phosphatase PTP1D is required for interferon alpha/beta-induced gene expression.
    David M; Zhou G; Pine R; Dixon JE; Larner AC
    J Biol Chem; 1996 Jul; 271(27):15862-5. PubMed ID: 8663536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals.
    Qu CK; Yu WM; Azzarelli B; Feng GS
    Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8528-33. PubMed ID: 10411909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence against dephosphorylation of insulin-elicited phosphotyrosine proteins in vivo by the phosphatase PTP2C.
    Kuhné MR; Zhao Z; Lienhard GE
    Biochem Biophys Res Commun; 1995 Jun; 211(1):190-7. PubMed ID: 7540003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysophosphatidic acid-induced association of SHP-2 with SHPS-1: roles of RHO, FAK, and a SRC family kinase.
    Takeda H; Matozaki T; Fujioka Y; Takada T; Noguchi T; Yamao T; Tsuda M; Ochi F; Fukunaga K; Narumiya S; Yamamoto T; Kasuga M
    Oncogene; 1998 Jun; 16(23):3019-27. PubMed ID: 9662335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An incomplete program of cellular tyrosine phosphorylations induced by kinase-defective epidermal growth factor receptors.
    Wright JD; Reuter CW; Weber MJ
    J Biol Chem; 1995 May; 270(20):12085-93. PubMed ID: 7538132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling capacity of the T cell antigen receptor is negatively regulated by the PTP1C tyrosine phosphatase.
    Pani G; Fischer KD; Mlinaric-Rascan I; Siminovitch KA
    J Exp Med; 1996 Sep; 184(3):839-52. PubMed ID: 9064344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positive regulation of c-Jun N-terminal kinase and TNF-alpha production but not histamine release by SHP-1 in RBL-2H3 mast cells.
    Xie ZH; Zhang J; Siraganian RP
    J Immunol; 2000 Feb; 164(3):1521-8. PubMed ID: 10640770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
    Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
    Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1).
    Florio T; Yao H; Carey KD; Dillon TJ; Stork PJ
    Mol Endocrinol; 1999 Jan; 13(1):24-37. PubMed ID: 9892010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase.
    Rocchi S; Tartare-Deckert S; Mothe I; Van Obberghen E
    Endocrinology; 1995 Dec; 136(12):5291-7. PubMed ID: 7588273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
    Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
    Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphotyrosines 627 and 659 of Gab1 constitute a bisphosphoryl tyrosine-based activation motif (BTAM) conferring binding and activation of SHP2.
    Cunnick JM; Mei L; Doupnik CA; Wu J
    J Biol Chem; 2001 Jun; 276(26):24380-7. PubMed ID: 11323411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling.
    Kim SO; Jiang J; Yi W; Feng GS; Frank SJ
    J Biol Chem; 1998 Jan; 273(4):2344-54. PubMed ID: 9442080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of neuregulin-mediated acetylcholine receptor synthesis by protein tyrosine phosphatase SHP2.
    Tanowitz M; Si J; Yu DH; Feng GS; Mei L
    J Neurosci; 1999 Nov; 19(21):9426-35. PubMed ID: 10531446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Negative regulation of PYK2/related adhesion focal tyrosine kinase signal transduction by hematopoietic tyrosine phosphatase SHPTP1.
    Kumar S; Avraham S; Bharti A; Goyal J; Pandey P; Kharbanda S
    J Biol Chem; 1999 Oct; 274(43):30657-63. PubMed ID: 10521452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of a catalytically inert Syp blocks activation of MAP kinase pathway downstream of p21ras.
    Sawada T; Milarski KL; Saltiel AR
    Biochem Biophys Res Commun; 1995 Sep; 214(2):737-43. PubMed ID: 7677789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SHP-2 binds to Tyr763 and Tyr1009 in the PDGF beta-receptor and mediates PDGF-induced activation of the Ras/MAP kinase pathway and chemotaxis.
    Rönnstrand L; Arvidsson AK; Kallin A; Rorsman C; Hellman U; Engström U; Wernstedt C; Heldin CH
    Oncogene; 1999 Jun; 18(25):3696-702. PubMed ID: 10391677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.